Breaking News
July 21, 2018 - Scientists identify potential target for the treatment of binge eating
July 21, 2018 - Whole-brain LIPUS therapy improves cognitive dysfunction in mice simulating dementia, Alzheimer’s
July 21, 2018 - Digital media use raising risk of ADHD symptoms among the young
July 21, 2018 - Phase 3 study of tanezumab in patients with osteoarthritis pain meets all three co-primary endpoints
July 21, 2018 - Restoring mitochondrial function to reverse aging-related skin wrinkles, hair loss in mice
July 21, 2018 - SP PennTech introduces RW-500 rotary vial washer for biotech, pharmaceutical applications
July 21, 2018 - Researchers to study molecular mechanisms behind susceptibility of males to autism
July 21, 2018 - Fourth Published Clinical Trial Confirms Long-Term Safety of Niagen Supplementation at High Doses and Shows Potential for Improvement in Liver Health
July 21, 2018 - Parents say intense gun violence in PG-13 movies appropriate for teens 15 and older
July 21, 2018 - FAU researchers find possible cause of Parkinson’s disease in the patients’ immune system
July 21, 2018 - Protective qualities of ‘good cholesterol’ reduce after menopause
July 21, 2018 - Researchers develop new way to uncover hidden breast cancer tumors
July 21, 2018 - FDA approves first drug for treatment of adult AML patients with specific genetic mutation
July 21, 2018 - Top AI companies join hands to discover novel drugs for DMD
July 21, 2018 - Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications
July 20, 2018 - Researchers design proteins that can self-assemble into complex structures
July 20, 2018 - AVITA Medical expands management team to support launch of RECELL device to treat burns
July 20, 2018 - FDA Approves Tibsovo (ivosidenib) for Relapsed or Refractory Acute Myeloid Leukemia with an IDH1 Mutation
July 20, 2018 - Developmental screening and surveillance rates remain low, new study suggests
July 20, 2018 - TGen opens tissue donation portal to advance DIPG research
July 20, 2018 - Health impact of highly processed summertime staples
July 20, 2018 - Exergaming can improve health in overweight and obese children, study shows
July 20, 2018 - Postmenopausal factors may impact heart-protective qualities of ‘good cholesterol’
July 20, 2018 - MRI and blood test combination results in improved prostate cancer diagnosis
July 20, 2018 - Update Health Professional and Consumer on Recent Recalled Products
July 20, 2018 - Researchers trace Parkinson’s damage in the heart
July 20, 2018 - Wearable device designed to measure cortisol in sweat
July 20, 2018 - Scientists demonstrate a new regulation mechanism for skeletal muscles
July 20, 2018 - Exposure to mobile phone radiation may negatively impact memory performance in adolescents
July 20, 2018 - SUSU scientists find alternative method to treat post-traumatic stress disorder syndrome
July 20, 2018 - Gestational diabetes may increase offspring’s heart disease risk
July 20, 2018 - New vaccine could protect unborn babies from Zika virus
July 20, 2018 - Researchers find high mercury and methylmercury concentrations in traditional Tibetan medicine
July 20, 2018 - Brief Safety Plan Intervention in ER Can Cut Suicidal Behavior
July 20, 2018 - Toward a better understanding of Parkinson’s disease
July 20, 2018 - Med school communications office wins four national awards | News Center
July 20, 2018 - Professional baseball players with faster hand-eye coordination may have better batting performance
July 20, 2018 - Study looks into mechanisms that control sleep and wakefulness
July 20, 2018 - Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments
July 20, 2018 - Research reveals long-term efficacy of drug used to treat common cause of kidney failure
July 20, 2018 - Timing of dinner associated with breast and prostate cancer risks
July 20, 2018 - Health Tip: Performing the Heimlich Maneuver
July 20, 2018 - Nearly all adolescents have eating, activity or weight-related issues
July 20, 2018 - Sage launches new web-based tool that helps explore curated genomic analyses of Alzheimer’s
July 20, 2018 - High-performance porous polymeric material for chromatography applications
July 20, 2018 - New molecule shows great promise for future treatment of many cancers
July 20, 2018 - New research project investigates alternative treatments for eye infections
July 20, 2018 - Immune T cells are built to react as fast as possible, shows study
July 20, 2018 - ZHX2 protein could offer a new treatment strategy for kidney cancer
July 20, 2018 - EKF’s Quo-Lab POC HbA1c analyzer meets international quality targets for diabetes testing
July 20, 2018 - Health burdens of very high risk drinking are potentially large, study reveals
July 20, 2018 - Using miniature drug-filled nanocarriers to target headaches and tumors
July 20, 2018 - Researchers uncover cause for progression of prostate cancer to incurable stage
July 20, 2018 - Studies highlight issues regarding black lung, opioid overdose, police violence and more
July 20, 2018 - AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia
July 20, 2018 - Researchers are one step closer to developing eye drops to treat age-related macular degeneration (AMD)
July 20, 2018 - Patients maintain muscle mass five years after surgically induced weight loss
July 20, 2018 - AMSBIO introduces new, powerful CRISPR/Cas9 gene editing kits
July 20, 2018 - PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides
July 20, 2018 - Analysis reveals disparities in cancer death rates among minority groups
July 20, 2018 - Dr Maddy Parsons receives Royal Microscopical Society Life Science Medal
July 20, 2018 - Study finds link between DNA methylation and non-alcoholic fatty liver disease
July 20, 2018 - Military personnel with head trauma and football players with suspected CTE show similar brain changes
July 20, 2018 - Vidac Pharma Announces Initiation of Phase 2b Clinical Trial of VDA-1102 Ointment in Patients with Actinic Keratosis
July 20, 2018 - KKR is buying Envision Healthcare in a nearly $10B deal
July 20, 2018 - Older people with broken bones face higher risk of death for up to 10 years
July 20, 2018 - A simple pill for meth addicts on the cards
July 20, 2018 - UA researchers to repurpose ketamine to reduce side effects in Parkinson’s patients
July 20, 2018 - Child psychiatrist available on call to help assess separated immigrant children
July 20, 2018 - High bitter-taste sensitivity linked to increased risk of cancer
July 20, 2018 - Falling temperatures may lead to rise in numbers of deaths from stroke
July 20, 2018 - Supplemental oxygen prevents rise in morning blood pressure in OSA patients
July 20, 2018 - High fruit and vegetable intake linked to reduced risk of breast cancer
July 20, 2018 - Careful patient selection may help achieve good outcomes for vaginal mesh surgery
July 20, 2018 - Researchers raise viability of cloned mice using somatic cell nuclear transfer method
July 20, 2018 - 3HP for Latent TB Infection Treatment | 2018 | Newsroom | NCHHSTP
July 20, 2018 - An orange a day keeps macular degeneration away: 15-year study
July 20, 2018 - Researchers elucidate how the brain drives trial-by-trial adaptation to compensate for errors
July 20, 2018 - Understanding triple-negative breast cancer to develop better treatments
July 20, 2018 - Study compares outpatient antibiotic prescribing with traditional medical, retail clinic settings
Post-CABG Afib Associated with Minimal Stroke Risk

Post-CABG Afib Associated with Minimal Stroke Risk

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study found that the risk of stroke was lower among patients with atrial fibrillation that developed after CABG compared to those who developed atrial fibrillation via other mechanisms.
  • Be aware this raises the question of whether anticoagulation should even be initiated for atrial fibrillation after CABG — a large clinical trial may be needed.

New-onset atrial fibrillation after coronary artery bypass grafting (CABG) surgery was associated with a lower, long-term thromboembolic risk than seen with nonsurgical, nonvalvular AF (NVAF), an observational study found.

The risk of thromboembolism — ischemic stroke, transient cerebral ischemia, and thrombosis or embolism in peripheral arteries — was lower in the postoperative AF (POAF) group than in the NVAF group (18.3 versus 29.7 events per 1,000 person-years; adjusted HR 0.67, 95% CI 0.55-0.81, P<0.001), Jawad Butts, MD, of Rigshospitalet Copenhagen University Hospital, and colleagues reported online March 28 in JAMA Cardiology.

This lower risk was despite substantially lower initiation of oral anticoagulation therapy within 30 days post-discharge in POAF (8.4%) compared with NVAF (42.9%).

In fact, patients who developed POAF following CABG had a statistically similar risk for vessel obstruction due to blood clots as patients who remained in sinus rhythm (adjusted HR 1.11, 95% CI 0.94-1.32, P<0.24).

The study is among the first to examining the long-term risk of thromboembolism associated with POAF following CABG, which occurs in 11% to 40% of patients, according to the researchers.

“Our data do not support the notion that new-onset POAFs should be regarded as similar to primary NVAF in terms of long-term thromboembolic risk,” wrote

The researchers noted that while oral anticoagulation clearly reduces stroke and systemic embolism risk in patients with NVAF, “data on stroke prophylaxis in new-onset POAF after CABG are lacking, and international guidelines on the management of patients with AF do not provide clear recommendations on this issue.”

Anticoagulation therapy during follow-up was associated with a lower risk of thromboembolic events in both patients with POAF (adjusted HR, 0.55, 95% CI, 0.32-0.95; P=0.03) and NVAF (adjusted HR, 0.59, 95% CI, 0.51-0.68; P<0.001) compared with patients who did not receive any anticoagulation therapy.

However, “no causal inferences can be made from the analysis on the effectiveness of oral anticoagulation (OAC) therapy for the prevention of thromboembolism in the two cohorts, although these data suggest that therapy is associated with a similar lower thromboembolic risk among groups,” the researchers cautioned.

Butts and colleagues used data from a clinical cardiac surgery database and nationwide patient registries in Denmark to identify patients undergoing first-time CABG surgery who developed new-onset POAF during a 15-year period beginning in 2000.

Each of those patients was matched by age, sex, CHA2DS2-VASc score and year of diagnosis to four patients with nonsurgical NVAF. In all, 2,108 post CABG patients who developed POAF were matched with 8,432 patients with NVAF.

Study limitations included the possibility of residual confounding associated with the observational design.

The study is not the first to suggest that new-onset AF following cardiac surgery poses a lower risk for stroke than traditional AF. Separate research published in 2014 by Whitlock et al. and Gialdini et al. also showed a lower risk for blood clots and stroke in patients who developed POAF.

The findings “have important implications for how clinicians should treat patients with this common problem,” Jeff Healey, MD, of McMaster University, Ontario, Canada, and colleagues, wrote in an invited commentary published with the study.

“It is likely that some AF following cardiac surgery is indeed transient and caused by inflammation, while in other cases, it is typical clinical AF in an at-risk individual that happens to receive a diagnosis for the first time in the postoperative setting,” they wrote, adding that it is not yet possible to distinguish between the two groups.

They concluded that given the observed lower risk for stroke associated with POAF in the three cohort studies and the low rate of oral anticoagulant use in the post-CABG AF setting, “there is clinical equipoise regarding the need for long-term oral anticoagulation therapy in this setting.”

“A large clinical trial would be invaluable to help resolve this uncertainty. Until such time, clinicians must use their best judgment regarding the need for long-term anticoagulation therapy,” they wrote.

The researchers reported no funding source nor disclosures of conflict of interest within the scope of this study.

Healey disclosed research grants from Bristol-Myers Squibb and Pfizer.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-03-28T14:45:00-0400

Tagged with:

About author

Related Articles